175 related articles for article (PubMed ID: 20443831)
1. ErbB2 induces Notch1 activity and function in breast cancer cells.
Lindsay J; Jiao X; Sakamaki T; Casimiro MC; Shirley LA; Tran TH; Ju X; Liu M; Li Z; Wang C; Katiyar S; Rao M; Allen KG; Glazer RI; Ge C; Stanley P; Lisanti MP; Rui H; Pestell RG
Clin Transl Sci; 2008 Sep; 1(2):107-15. PubMed ID: 20443831
[TBL] [Abstract][Full Text] [Related]
2. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
Montañez-Wiscovich ME; Seachrist DD; Landis MD; Visvader J; Andersen B; Keri RA
Oncogene; 2009 Oct; 28(41):3608-18. PubMed ID: 19648968
[TBL] [Abstract][Full Text] [Related]
3. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.
Zhang Q; Sakamoto K; Liu C; Triplett AA; Lin WC; Rui H; Wagner KU
Cancer Res; 2011 Dec; 71(24):7513-24. PubMed ID: 22037875
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation.
Koziczak M; Hynes NE
J Biol Chem; 2004 Nov; 279(48):50004-11. PubMed ID: 15377668
[TBL] [Abstract][Full Text] [Related]
7. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract][Full Text] [Related]
8. ErbB2 down-regulates microRNA-205 in breast cancer.
Adachi R; Horiuchi S; Sakurazawa Y; Hasegawa T; Sato K; Sakamaki T
Biochem Biophys Res Commun; 2011 Aug; 411(4):804-8. PubMed ID: 21787752
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.
Lee RJ; Albanese C; Fu M; D'Amico M; Lin B; Watanabe G; Haines GK; Siegel PM; Hung MC; Yarden Y; Horowitz JM; Muller WJ; Pestell RG
Mol Cell Biol; 2000 Jan; 20(2):672-83. PubMed ID: 10611246
[TBL] [Abstract][Full Text] [Related]
11. C-erbB2, p27 and G1/S aberrations in human primary breast cancer.
Lodén M; Perris F; Nielsen NH; Emdin SO; Landberg G
Anticancer Res; 2003; 23(3A):2053-61. PubMed ID: 12894578
[TBL] [Abstract][Full Text] [Related]
12. Rate-limiting effects of Cyclin D1 in transformation by ErbB2 predicts synergy between herceptin and flavopiridol.
Nahta R; Iglehart JD; Kempkes B; Schmidt EV
Cancer Res; 2002 Apr; 62(8):2267-71. PubMed ID: 11956082
[TBL] [Abstract][Full Text] [Related]
13. Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise.
Ling H; Jolicoeur P
Oncogene; 2013 Jul; 32(29):3410-9. PubMed ID: 22907433
[TBL] [Abstract][Full Text] [Related]
14. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
15. The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer.
Yang C; Ionescu-Tiba V; Burns K; Gadd M; Zukerberg L; Louis DN; Sgroi D; Schmidt EV
Am J Pathol; 2004 Mar; 164(3):1031-8. PubMed ID: 14982856
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis.
Sequeira SJ; Wen HC; Avivar-Valderas A; Farias EF; Aguirre-Ghiso JA
BMC Cell Biol; 2009 Sep; 10():64. PubMed ID: 19754954
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo.
Xu P; Qiu M; Zhang Z; Kang C; Jiang R; Jia Z; Wang G; Jiang H; Pu P
J Neurooncol; 2010 Mar; 97(1):41-51. PubMed ID: 19771395
[TBL] [Abstract][Full Text] [Related]
18. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
[TBL] [Abstract][Full Text] [Related]
19. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
